The product contains lidocaine which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging is not child resistant, posing a risk of poisoning to young children if they ingest the anesthetic cream.
You are here: Home / Product Recalls / CPSC Press Releases / Mohnark Pharmaceuticals Recalls Lidocaine Topical Anesthetic Cream Due to Failure to Meet Child-Resistant Packaging Requirement; Risk of Poisoning (Recall Alert)
About The CPSC
CPSC is charged with protecting the public from unreasonable risks of injury or death associated with the use of the thousands of types of consumer products under the agency's jurisdiction.
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Leave a Reply